Polymer particles
US-9938367-B2 · Apr 10, 2018 · US
US10155064B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10155064-B2 |
| Application number | US-201815878294-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 23, 2018 |
| Priority date | Mar 26, 2015 |
| Publication date | Dec 18, 2018 |
| Grant date | Dec 18, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Embolic particles are described. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer.
Opening claim text (preview).
We claim: 1. An embolic system including: a catheter; and spherical embolic particles having an organic polymer backbone including a reaction product of a prepolymer solution including: a poly(ethylene glycol) diacrylamide macromer, a poly(ethylene glycol) diacrylate macromer, a poly(ethylene glycol) dimethacrylate macromer, a poly(ethylene glycol) dimethacrylamide macromer, or a combination thereof; and at least one monomer, wherein the spherical embolic particles have a diameter between about 50 μm and about 1,500 μm. 2. The embolic system of claim 1 , wherein the diameter is between about 400 μm and about 1,500 μm. 3. The embolic system of claim 1 , wherein the catheter is a microcatheter. 4. The embolic system of claim 1 , wherein the at least one monomer includes ionic groups. 5. The embolic system of claim 4 , wherein the monomer containing ionic groups is sodium acrylate. 6. The embolic system of claim 1 , wherein the prepolymer solution further includes a crosslinker. 7. The embolic system of claim 6 , wherein the crosslinker is biodegradable. 8. The embolic system of claim 6 , wherein the crosslinker has a structure: wherein each n is independently 1-20; wherein d, e, f, and g are each independently 1-20; or 9. The embolic system of claim 1 , wherein the spherical embolic particles further include a visualization agent having a structure: 10. A method of treatment, the method comprising: delivering spherical embolic particles having an organic polymer backbone through a catheter to a treatment site, wherein the spherical embolic particles are formed from a reaction product of a prepolymer solution including: a poly(ethylene glycol) diacrylamide macromer, a poly(ethylene glycol) diacrylate macromer, a poly(ethylene glycol) dimethacrylate macromer, a poly(ethylene glycol) dimethacrylamide macromer, or a combination thereof; and at least one monomer, wherein the spherical embolic particles have a diameter between about 50 μm and about 1,500 μm. 11. The method of claim 10 , wherein the delivering includes flushing the catheter with a non-solvent. 12. The method of claim 11 , wherein the non-solvent is a mineral oil, hexane, or water. 13. The method of claim 11 , wherein the diameter is between about 400 μm and about 1,500 μm. 14. The method of claim 11 , wherein the catheter is a microcatheter. 15. The method of claim 11 , wherein the at least one monomer includes ionic groups. 16. The method of claim 15 , wherein the monomer containing ionic groups is sodium acrylate. 17. The method of claim 11 , wherein the prepolymer solution further includes a crosslinker. 18. The method of claim 17 , wherein the crosslinker is biodegradable. 19. The method of claim 17 , wherein the crosslinker has a structure: wherein each n is independently 1-20; wherein d, e, f, and g are each independently 1-20; or 20. The method of claim 11 , wherein the spherical embolic particles further include a visualization agent having a structure:
for embolization or occlusion, e.g. vaso-occlusive compositions or devices · CPC title
Use of materials characterised by their function or physical properties · CPC title
obtained by reactions only involving carbon-to-carbon unsaturated bonds {(A61L24/043, A61L24/046 take precedence)} · CPC title
Monomers containing two or more (meth)acrylamide groups, e.g. N,N'-methylenebisacrylamide · CPC title
Homopolymers or copolymers of acrylamide or methacrylamide · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.